| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020573A1 Growth factor receptor-binding protein 2 homolog |
| 06/12/1997 | WO1997020563A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 06/12/1997 | WO1997011169A3 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2238981A1 Viral vectors |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238379A1 Ligands to enhance cellular uptake of biomolecules |
| 06/11/1997 | EP0778349A2 Gene construct and the use thereof |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777732A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777728A1 Polycystic kidney disease 1 gene and uses thereof |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0544824B1 Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/10/1997 | US5637483 Irradiated tumor cell vaccine engineered to express GM-CSF |
| 06/10/1997 | US5637471 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 06/05/1997 | WO1997020075A1 Screening assay for compounds stimulating somatostatin and insulin production |
| 06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020051A2 Vectors and methods for gene transfer to cells |
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997020049A1 Human peptide circulating in the blood and possessing insulinotropic properties |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997020045A2 P2u2 PURINERGIC RECEPTOR |
| 06/05/1997 | WO1997020038A1 Compositions and methods for site-directed integration into dna |
| 06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019675A2 Complex cationic lipids |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | WO1997007219A3 Genes and proteins controlling cholesterol synthesis |
| 06/05/1997 | WO1996039530A3 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | CA2237937A1 Novel purinergic receptor |
| 06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
| 06/04/1997 | EP0776361A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776327A1 New multimerizing agents |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/03/1997 | US5635487 Drug delivery |
| 06/03/1997 | US5635479 Anticarginic agents, ovarian cancer |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 06/03/1997 | US5635386 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
| 06/03/1997 | US5635385 Multi-unit ribozyme inhibition of oncogene gene expression |
| 06/03/1997 | US5635380 Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids |
| 06/03/1997 | US5635355 Methods of obtaining a DNA sequence for integration site independent gene expression |
| 06/03/1997 | US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex |
| 05/29/1997 | WO1997019183A2 Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer |
| 05/29/1997 | WO1997019182A1 Production of retroviral vectors using herpes vectors |
| 05/29/1997 | WO1997019181A2 Virus vector for the transfer of stable episomes |
| 05/29/1997 | WO1997019180A2 Vector consisting of a transcriptional regulatory dna sequence linked to a dna sequence encoding beta-lactamase for enzyme prodrug therapy |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019168A1 Sequestrin |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997018837A1 Novel non-pyrogenic bacterial strains and use of the same |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997006247A3 Deubiquitinating enzymes that regulate cell growth |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775207A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |